STERIS plc (STE) Gross Margin
- Gross margin · 12 months: Value 44.43%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 44.43% | Gross profit / revenue. Period ending 2026-06-30. $2.68B ÷ $6.04B × 100 ≈ 44.43% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 2.68B USD | Gross Profit |
| Revenue | 6.04B USD | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $2.68B | $6.04B | (m) | 44.43% |
| 2026-03-31 | $2.63B | $5.94B | $3.31B | 44.25% |
| 2025-12-31 | $2.57B | $5.83B | (m) | 44.11% |
| 2025-09-30 | $2.53B | $5.70B | (m) | 44.29% |
| 2025-06-30 | $2.46B | $5.57B | (m) | 44.13% |
| 2025-03-31 | $2.40B | $5.46B | $3.06B | 44.01% |
| 2024-12-31 | $2.34B | $5.40B | (m) | 43.43% |
| 2024-09-30 | $2.29B | $5.33B | (m) | 43.08% |
| 2024-06-30 | $2.26B | $5.23B | (m) | 43.20% |
| 2024-03-31 | $2.22B | $5.14B | $2.92B | 43.17% |
| 2023-12-31 | $2.36B | $5.41B | (m) | 43.60% |
| 2023-09-30 | $2.28B | $5.23B | (m) | 43.55% |
| 2023-06-30 | $2.22B | $5.09B | (m) | 43.56% |
| 2023-03-31 | $2.16B | $4.96B | $2.80B | 43.56% |
| 2022-12-31 | $2.14B | $4.78B | (m) | 44.80% |
| 2022-09-30 | $2.16B | $4.78B | (m) | 45.22% |
| 2022-06-30 | $2.11B | $4.77B | $2.67B | 44.16% |
| 2022-03-31 | $2.02B | $4.59B | $2.57B | 43.98% |
| 2021-12-31 | $1.82B | $4.25B | (m) | 42.95% |
| 2021-09-30 | $1.63B | $3.85B | (m) | 42.42% |
| 2021-06-30 | $1.48B | $3.41B | (m) | 43.50% |
| 2021-03-31 | $1.34B | $3.11B | $1.76B | 43.22% |
| 2020-12-31 | $1.33B | $3.06B | (m) | 43.36% |
| 2020-09-30 | $1.31B | $3.02B | (m) | 43.38% |
| 2020-06-30 | $1.30B | $3.00B | (m) | 43.28% |
| 2020-03-31 | $1.32B | $3.03B | (m) | 43.55% |
| 2019-12-31 | $1.29B | $2.98B | (m) | 43.36% |
| 2019-09-30 | $1.25B | $2.90B | (m) | 43.00% |
| 2019-06-30 | $1.21B | $2.84B | (m) | 42.68% |
| 2019-03-31 | $1.18B | $2.78B | (m) | 42.25% |
| 2018-12-31 | $1.13B | $2.73B | (m) | 41.51% |
| 2018-09-30 | $1.12B | $2.70B | (m) | 41.71% |
| 2018-06-30 | $1.11B | $2.65B | (m) | 41.72% |
| 2018-03-31 | $1.09B | $2.62B | (m) | 41.71% |
| 2017-12-31 | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | $1.03B | $2.61B | (m) | 39.28% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |